WallStreetZenWallStreetZen

NASDAQ: BDSX
Biodesix Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BDSX past revenue growth

How has BDSX's revenue growth performed historically?
Company
33.24%
Industry
1.91%
Market
13.73%
BDSX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BDSX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BDSX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BDSX earnings and revenue history

Current Revenue
$41.6M
Current Earnings
-$66.1M
Current Profit Margin
-158.7%

BDSX Return on Equity

Current Company
-1,732.5%
Current Industry
-75.3%
Current Market
22.1%
BDSX's Return on Equity (-1,732.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BDSX announces earnings.

BDSX Return on Assets

Current Company
-84.1%
Current Industry
5.6%
BDSX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BDSX Return on Capital Employed

Current Company
-112.11%
Current Industry
10.3%
BDSX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BDSX vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BDSX$41.64M-$49.41M-$66.10M+97.70%N/A
FONR$98.65M$21.86M$8.80M+3.89%-15.64%
BNR$80.67MN/A-$105.26M+82.73%N/A
NVTA$493.88M-$598.31M-$799.67M+35.40%N/A
DRIO$26.63M-$52.75M-$60.11M+31.52%N/A
View Top Diagnostic & Research Stocks

BDSX earnings dates

Next earnings date
Oct 9, 2023

Biodesix Earnings & Revenue FAQ

What were BDSX's earnings last quarter?

On Invalid Date, Biodesix (NASDAQ: BDSX) reported Q2 2023 earnings per share (EPS) of -$0.17, up 57.5% year over year. Total Biodesix earnings for the quarter were -$13.36 million. In the same quarter last year, Biodesix's earnings per share (EPS) was -$0.40.

If you're new to stock investing, here's how to buy Biodesix stock.

What was BDSX's earnings growth in the past year?

As of Q3 2023, Biodesix's earnings has grown year over year. Biodesix's earnings in the past year totalled -$66.10 million.

What is BDSX's earnings date?

Biodesix's earnings date is Invalid Date. Add BDSX to your watchlist to be reminded of BDSX's next earnings announcement.

What was BDSX's revenue last quarter?

On Invalid Date, Biodesix (NASDAQ: BDSX) reported Q2 2023 revenue of $11.87 million up 8.42% year over year. In the same quarter last year, Biodesix's revenue was $10.95 million.

What was BDSX's revenue growth in the past year?

As of Q3 2023, Biodesix's revenue has grown 33.24% year over year. This is 31.33 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 1.91%. Biodesix's revenue in the past year totalled $41.64 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.